Slide 1: Market Announcement: Investor Presentation
Integrated Research Ltd > ABN 76 003 588 449 Suite 9.03, Level 9, 420 George Street, Sydney NSW 2000 Australia t: +61 (2) 9966 1066 e: InfoAP@ir.com Market Announcement Investor Presentation Sydney, 27 August 2026 – Further to Integrated Research Limited’s (Company, IR) (ASX:IRI) announcement to the
Slide 2: Integrated Research FY26 Results
For personal use only ABOUT IR INTEGRATED RESEARCH (ASX:IRI) FY26 RESULTS 27th August 2026 2
Slide 3: Disclaimer
Disclaimer For personal use only SUM MARY INF ORMATION FORWARD LOOKING STATEMENTS NOT AN OFFER This do cume nt and the as soci ated transcr ipt (to geth er “th e The pres entation con tain s certain "forward-loo kin g s tatemen ts”. Th e The pres entation is fo r info rmation pu rpo ses on ly an d i
Slide 4: FY26 Results Business Update
For personal use only FY26 RESULTS BUSINESS UPDATE Ian Lowe, CEO and Managing Director
Slide 5: IR trusted by the world's leading global enterprises
IR…TRUSTED BY THE WORLD’S LEADING GLOBAL ENTERPRISES For personal use only Tech | Telco BFSI Health | Gov | Edu Retail | Industrial Leading telco companies Leading USA banks Fortune 500 companies Leading large enterprises 4
Slide 6: FY26 Key Themes
FY26 RESULTS FY26 KEY THEMES For personal use only Continued product-led growth execution Progress against new product agenda - new AI products launched, product investment ongoing, new product releases to continue. FY26 financial performance Strong cash generation and cash balance - increased divid
Slide 7: Product-led growth highlights
COLLABORATE FY26 RESULTS PRODUCT-LED GROWTH HIGHLIGHTS: For personal use only New products delivered, first client activations: • Iris: AI interface integrated into Prognosis, powers deeper discovery and foundational to expanded AI offering, first clients activated. • First IR Labs product: Beta lau
Slide 8: FY26 Results Financial Update
For personal use only FY26 RESULTS FINANCIAL UPDATE Christian Shaw, CFO
Slide 9: FY26 Key Financial Metrics
FINANCIALS FY26 KEY FINANCIAL METRICS For personal use only Pro forma Revenue Statutory Revenue EBITDA $65.8m $57.6m ($2.1m) Down 12% on FY25 Down 16% on FY25 Down on FY25 $15.9m Ordinary Dividend Special Dividend NPAT Net Cash (Fully Franked) (Fully Franked) $1.2m $51.7m $0.03 $0.02 Down 91% on FY2
Slide 10: Pro Forma Revenue
FINANCIALS PRO FORMA REVENUE For personal use only 74.3 6.8 65.8 5.4 FY26 Pro forma Revenue: $65.8m (down 12%). Pro forma revenue apportions upfront license fee revenue evenly over the life of the contract. 92% of Pro forma revenue is secured via term-based 67.5 60.4 contracts. Pro forma revenue dec
Slide 11: Pro Forma Revenue by Territory and Product
FINANCIALS PRO FORMA REVENUE BY TERRITORY AND PRODUCT For personal use only Pro forma revenue declines across all territories and products. TERRITORY (A$M) PRODUCT (A$M) EUROPE 7.0 Infrastructure 18.7 Collaborate AMERICAS APAC 32.2 45.0 13.8 Transact 14.9 • Americas down 13% vs PCP. Collaborate redu
Slide 12: Statutory Revenue
FINANCIALS STATUTORY REVENUE For personal use only Down 16% vs PCP 68.3 6.5 57.6 3.9 FY26 Statutory Revenue: $57.6m (down 16%) 5.4 13.2 1.8 Revenue recognised at a point in time was $38.8m vs $44.6m in 11.6 FY25. Licence fees were down 13%, maintenance fees down 12% and 44.6 subscription fees down 5
Slide 13: Statutory EBITDA
FINANCIALS STATUTORY EBITDA For personal use only FY26 EBITDA Loss of $2.1m In A$M FY26 FY25 Change % EBITDA moved from a $15.9m profit in FY25 to a $2.1m Total revenue 57.6 68.3 (16%) loss, driven by lower revenue and expected credit losses and adverse FX movement. Expected credit losses 5.0 0.1 NM
Slide 14: Balance Sheet & Cash Generation
FINANCIALS BALANCE SHEET & CASH GENERATION For personal use only Period Ended Jun-26 Jun-25 Change % A$M A$M Cash & equivalents 51.7 40.6 27% Trade & other receivables 58.2 73.7 (21%) All other assets 9.4 8.7 9% Strong balance sheet with cash of Net cash from operating activities $51.7m and no debt.
Slide 15: FY27 Capital Allocation Framework
FINANCIALS FY27 CAPITAL ALLOCATION FRAMEWORK For personal use only Investing for Product-Led Growth Innovation investment • Product innovation across the Prognosis platform & IR-Labs (AI-first innovation lab). • 30%-35% of available capital allocated to product innovation in the medium term . Flexib
Slide 16: FY26 Results Product-Led Growth Update
For personal use only FY26 RESULTS PRODUCT-LED GROWTH UPDATE Ian Lowe, CEO and Managing Director
Slide 17: Product-Led Growth (PLG)
PLG STRATEGY PRODUCT-LED GROWTH (PLG) For personal use only Focused PLG strategy execution has delivered new products and revenue models. FY27 focus is to improve innovation and commercialisation cadence. Investment in new products is essential to establish sustainable revenue growth over the medium
Slide 18: Key Growth Metrics
PLG STRATEGY KEY GROWTH METRICS For personal use only New client wins, revenue growth from new products still to emerge. New Client Revenue Expansion Revenue Subscription Fees $5.5m $2.9m $1.8m Down 18% on FY25 Down 12% on FY25 Down 54% on FY25 Licence fee revenue Early stages of releasing Utilisati
Slide 19: Product-Led Growth (PLG)
PLG STRATEGY PRODUCT-LED GROWTH (PLG) For personal use only Focused PLG strategy execution has delivered new products and revenue models. FY27 focus is to improve velocity of innovation and commercialisation. New product enhancements Agentic Product Innovation Elevate Iris SQA Prognosis as AI powere
Slide 20: Observations
FY26 RESULTS OBSERVATIONS For personal use only • AI is both a disruptor and an enabler. IR is responding in three primary ways: 1. AI as innovation driver - embedding it into our product offering (eg. Iris). 2. Building new, stand-alone products that are born AI enabled (eg. IR Labs). 3. Integratin
Slide 21: Summary
FY26 RESULTS SUMMARY For personal use only FY26 Results • FY26 final fully franked dividend of $0.05 per share comprising of an ordinary dividend of $0.03 per share (FY25: $0.02) and a special dividend of $0.02 per share. • Lower FY26 revenue reflective of softer renewals book and new business contr
Slide 22: Thank You
For personal use only FY26 RESULTS THANK YOU
Slide 23: Appendix
For personal use only FY26 RESULTS APPENDIX
Slide 24: Total Contract Value (TCV)
FINANCIALS TOTAL CONTRACT VALUE (TCV) For personal use only New business TCV of $10.9m, down 21% vs PCP 67.3 4.9 54.3 FY26 TCV: $54.3m (down 19%) 13.8 4.9 TCV is the total value of client contracts 10.9 secured in any given period. FY26 renewals of $38.5m and new business 48.6 of $10.9m, both down 2
Slide 25: EBITDA Cash Flow Bridge
FINANCIALS EBITDA CASH FLOW BRIDGE ($M) For personal use only Net cash from operating activities of $12.6m, up from $8.7m in FY25. Interest received of $3.6m and dividends paid of $3.5m. Closing cash of $51.7m, up 27% on Jun 25, with no debt. • FY26 Pro forma EBITDA exceeded statutory EBITDA by $10.
Slide 26: Operating Expenses
FINANCIALS OPERATING EXPENSES – A$M For personal use only Disciplined cost management • Total operating expenses of $58.8m Total expenditure Product and Technology includes credit losses and depreciation & amortisation. 54.9 58.8 • FY25 to FY26 product and technology expense movement reflects invest
Slide 27: Reconciliation of Revenue and Pro Forma Revenue, NPAT to EBITDA
FINANCIALS RECONCILIATION OF REVENUE AND PRO FORMA REVENUE, AND NET For personal use only PROFIT AFTER TAX (NPAT) TO EBITDA AND PRO FORMA EBITDA Full year results - $M FY26 FY25 1 Pro forma revenue provides a non-statutory alternate view of underlying Revenue 57.6 68.3 performance by restating term
Slide 28: FY26 Pro Forma Recurring Revenue
FINANCIALS FY26 PRO FORMA RECURRING REVENUE For personal use only Reconciliation of statutory to pro forma revenue Full Year Revenue FY23 FY24 FY25 FY26 FY24 FY25 FY26 $M $M $M $M %chg. %chg. %chg. Infrastructure 18.6 19.2 19.9 17.7 4% 3% (11%) Transact 11.5 12.7 16.3 14.1 11% 29% (13%) Collaborate
Slide 29: Glossary
FINANCIALS GLOSSARY For personal use only EBITDA EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortisation) is a non-IFRS measure used to evaluate the Company's operating performance by focusing on profit from core operations and excluding the effects of capital structure, tax rates, an